At DDW 2016, OpenBiome presented data (abstract Su1737) from 2,050 patients who received fecal microbiata transplants (FMT) in “the real world.”
Key findings:
- Overall, 84% clinical cure rate with a single treatment
- 85% of patients were treated with FMT via colonoscopy (250 mL) and 15% via nasal tube (50 mL). Nasal tube administration had a lower clinical cure rate of 77.9%, compared with 85.1% who had FMT via colonoscopy.
More information on this study: “Closet Thing to Miracle Cure”: Study Confirms Benefit of FMT in C difficile Gastroenterology & Endoscopy News July 2016 This link also presents data on use of FMT in ulcerative colitis and the use of capsule FMT.
Related blog posts:
- Consensus Guidelines on FMT | gutsandgrowth
- Fecal Transplantation: “Frozen is as Good as Fresh” | gutsandgrowth
- Rejected! Most Stool is Not Good Enough for FMT | gutsandgrowth
- Clostridium difficile/Fecal Microbiota Transplantation … – gutsandgrowth
- Another Way of Preventing Recurrent Clostridium … – gutsandgrowth
gutsandgrowth 
Pingback: Large Study Shows FMT Efficacy/Safety in Children | gutsandgrowth
Pingback: Two Studies: 1. COVID-19 Transmissibility 2.Fecal Microbiota Transplantation in 372 Children | gutsandgrowth
Pingback: “Real-world” Efficacy for Fecal Microbiota Transplantation | gutsandgrowth